DHL Expands Healthcare Capabilities with Acquisition of SDS Rx, Pending Regulatory Approvals

Reuters

Sep 09

DHL Expands Healthcare Capabilities with Acquisition of SDS Rx, Pending Regulatory Approvals

Deutsche Post AG's DHL Supply Chain has announced an agreement to acquire SDS Rx, a move set to expand its capabilities in life sciences and healthcare logistics. This strategic acquisition will enhance DHL's healthcare logistics portfolio, particularly in delivering integrated, time-critical solutions across the life sciences and healthcare supply chain. With SDS Rx's expertise in processing specialized healthcare deliveries and final-mile logistics services, DHL aims to strengthen its service offerings in long-term care, specialty pharmacies, radiopharmacies, and health system networks. This marks DHL's second healthcare acquisition in 2025, following its earlier purchase of CryoPDP, and aligns with its Strategy 2030 growth agenda.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Deutsche Post AG published the original content used to generate this news brief on September 09, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2566613133"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2566613133\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2566613133?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-09 22:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2566613133","market":"us","top_or_hot":-1,"title":"DHL Expands Healthcare Capabilities with Acquisition of SDS Rx, Pending Regulatory Approvals","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      DHL Expands Healthcare Capabilities with Acquisition of SDS Rx, Pending Regulatory Approvals\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/DHLGY\">Deutsche Post AG</a>'s DHL Supply Chain has announced an agreement to acquire SDS Rx, a move set to expand its capabilities in life sciences and healthcare logistics. This strategic acquisition will enhance DHL's healthcare logistics portfolio, particularly in delivering integrated, time-critical solutions across the life sciences and healthcare supply chain. With SDS Rx's expertise in processing specialized healthcare deliveries and final-mile logistics services, DHL aims to strengthen its service offerings in long-term care, specialty pharmacies, radiopharmacies, and health system networks. This marks DHL's second healthcare acquisition in 2025, following its earlier purchase of CryoPDP, and aligns with its <a href=\"https://laohu8.com/S/MSTR\">Strategy</a> 2030 growth agenda.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. <a href=\"https://laohu8.com/S/DPSGY\">Deutsche Post AG</a> published the original content used to generate this news brief on September 09, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>DHL Expands Healthcare Capabilities with Acquisition of SDS Rx, Pending Regulatory Approvals</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDHL Expands Healthcare Capabilities with Acquisition of SDS Rx, Pending Regulatory Approvals\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-09-09 22:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      DHL Expands Healthcare Capabilities with Acquisition of SDS Rx, Pending Regulatory Approvals\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/DHLGY\">Deutsche Post AG</a>'s DHL Supply Chain has announced an agreement to acquire SDS Rx, a move set to expand its capabilities in life sciences and healthcare logistics. This strategic acquisition will enhance DHL's healthcare logistics portfolio, particularly in delivering integrated, time-critical solutions across the life sciences and healthcare supply chain. With SDS Rx's expertise in processing specialized healthcare deliveries and final-mile logistics services, DHL aims to strengthen its service offerings in long-term care, specialty pharmacies, radiopharmacies, and health system networks. This marks DHL's second healthcare acquisition in 2025, following its earlier purchase of CryoPDP, and aligns with its <a href=\"https://laohu8.com/S/MSTR\">Strategy</a> 2030 growth agenda.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. <a href=\"https://laohu8.com/S/DPSGY\">Deutsche Post AG</a> published the original content used to generate this news brief on September 09, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CYRX","symbol_name":"CryoPort, Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250909:nNDL3fzJQc:1","article_id":"2566613133","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2566613133","pubTimestamp":1757426827,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Deutsche Post AG's DHL Supply Chain has announced an agreement to acquire SDS Rx, a move set to expand its capabilities in life sciences and healthcare logistics. This strategic acquisition will enhance DHL's healthcare logistics portfolio, particularly in delivering integrated, time-critical solutions across the life sciences and healthcare supply chain. With SDS Rx's expertise in processing specialized healthcare deliveries and final-mile logistics services, DHL aims to strengthen its service offerings in long-term care, specialty pharmacies, radiopharmacies, and health system networks. This marks DHL's second healthcare acquisition in 2025, following its earlier purchase of CryoPDP, and aligns with its Strategy 2030 growth agenda.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpret","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CYRX":"CryoPort, Inc.","BK4602":"量子计算概念","BK4082":"医疗保健设备","BK4121":"生命科学工具和服务"},"translate_title":"DHL通过收购SDS Rx扩大医疗保健能力，等待监管部门批准","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CYRX":0.9},"content_text":"DHL Expands Healthcare Capabilities with Acquisition of SDS Rx, Pending Regulatory Approvals\n    \n\nDeutsche Post AG's DHL Supply Chain has announced an agreement to acquire SDS Rx, a move set to expand its capabilities in life sciences and healthcare logistics. This strategic acquisition will enhance DHL's healthcare logistics portfolio, particularly in delivering integrated, time-critical solutions across the life sciences and healthcare supply chain. With SDS Rx's expertise in processing specialized healthcare deliveries and final-mile logistics services, DHL aims to strengthen its service offerings in long-term care, specialty pharmacies, radiopharmacies, and health system networks. This marks DHL's second healthcare acquisition in 2025, following its earlier purchase of CryoPDP, and aligns with its Strategy 2030 growth agenda.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Deutsche Post AG published the original content used to generate this news brief on September 09, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}